- Home
- CRNX vs TGNA Comparison
CRNX vs TGNA Comparison
Compare CRNX & TGNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- TGNA
- Stock Information
- Founded
- CRNX 2008
- TGNA 1906
- Country
- CRNX United States
- TGNA United States
- Employees
- CRNX N/A
- TGNA N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- TGNA Broadcasting
- Sector
- CRNX Health Care
- TGNA Industrials
- Exchange
- CRNX Nasdaq
- TGNA Nasdaq
- Market Cap
- CRNX 2.8B
- TGNA 3.3B
- IPO Year
- CRNX 2018
- TGNA N/A
- Fundamental
- Price
- CRNX $41.56
- TGNA $19.94
- Analyst Decision
- CRNX Buy
- TGNA Buy
- Analyst Count
- CRNX 12
- TGNA 4
- Target Price
- CRNX $74.45
- TGNA $20.00
- AVG Volume (30 Days)
- CRNX 2.1M
- TGNA 2.6M
- Earning Date
- CRNX 11-06-2025
- TGNA 11-06-2025
- Dividend Yield
- CRNX N/A
- TGNA 2.51%
- EPS Growth
- CRNX N/A
- TGNA 15.85
- EPS
- CRNX N/A
- TGNA 2.77
- Revenue
- CRNX $1,392,000.00
- TGNA $3,032,450,000.00
- Revenue This Year
- CRNX $428.87
- TGNA N/A
- Revenue Next Year
- CRNX $958.11
- TGNA $11.44
- P/E Ratio
- CRNX N/A
- TGNA $7.20
- Revenue Growth
- CRNX 0.51
- TGNA 5.89
- 52 Week Low
- CRNX $24.10
- TGNA $14.87
- 52 Week High
- CRNX $62.53
- TGNA $21.35
- Technical
- Relative Strength Index (RSI)
- CRNX 54.07
- TGNA 42.14
- Support Level
- CRNX $43.72
- TGNA $19.73
- Resistance Level
- CRNX $45.95
- TGNA $20.38
- Average True Range (ATR)
- CRNX 1.78
- TGNA 0.21
- MACD
- CRNX -0.37
- TGNA -0.09
- Stochastic Oscillator
- CRNX 19.30
- TGNA 25.32
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About TGNA TEGNA Inc
Tegna Inc is a media company with a portfolio of broadcast stations and digital sites. The firm has television stations and radio stations in approximately U.S. markets. The company owns multicast networks of True Crime Network, Twist, and Quest. Each television station also has a robust digital presence across online, mobile, connected television, and social platforms, reaching consumers on all devices and platforms used to consume news content. It generates key revenue from advertising and marketing services, subscriptions, political advertising, and other services.